In February 2022, Nthoptic (Suzhou) Optic Technology Co., LTD. was officially established, marking the rise of a new star in the field of eye health and injecting new vitality and development momentum into the entire industry.
In March 2023, the online launch meeting of the global multi-center clinical trial for the S.T.O.P KIT myopia control project by Nthoptic Vision was successfully held.
During the 22nd COOC International Optometry Conference in 2023, Nthoptic announced the completion of tens of millions of angel round financing. The financing round was led by Shuimu Ventures and followed by Qingshi Capital. The funds raised will be used to accelerate product innovation, technology research and development, and launch their nearsightedness prevention product - S.T.O.P KIT's global multicenter clinical trials.
During the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) in 2023, Nthoptic Vision presented their research reports on "S.T.O.P KIT Visual Quality Study" and "S.T.O.P KIT Optical Modeling and Model Eye Analysis" to the academic community from around the world. The reports showed that this new type of optical film can effectively help control the progression of myopia in young people, providing protection for children's eye health.
【Scan and follow us】
